We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.92%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$6.75B
AUM Growth
+$963M
(+17%)
Cap. Flow
+$702M
Cap. Flow
% of AUM
10.4%
Top 10 Holdings %
Top 10 Hldgs %
4.5%
Holding
2,736
New
363
Increased
1,147
Reduced
950
Closed
272
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$38.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$31M |
| 3 |
Linde
LIN
|
+$30.2M |
| 4 |
Nike
NKE
|
+$27.1M |
| 5 |
EOG Resources
EOG
|
+$26.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$35.3M |
| 2 |
Home Depot
HD
|
+$29.9M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$26.7M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$26M |
| 5 |
Lockheed Martin
LMT
|
+$25.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.68% |
| 2 | Consumer Discretionary | 15.21% |
| 3 | Industrials | 13.29% |
| 4 | Financials | 13.24% |
| 5 | Healthcare | 12.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMA
2376
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $44K | ﹤0.01% |
10,209
+7,409
| +265% | +$35.5K |
|
2377
Comstock Resources
CRK
$3.94B
| $42K | ﹤0.01% |
9,492
-62,707
| -87% | -$332K |
|
2378
Arcutis Biotherapeutics
ARQT
$3.18B
| $41K | ﹤0.01% |
+1,407
| New | +$37.6K |
|
|
GOCO
2379
DELISTED
GoHealth
GOCO
| $41K | ﹤0.01% |
+212
| New | +$51K |
|
2380
Transocean
RIG
$5.82B
| $41K | ﹤0.01% |
50,307
+33,607
| +201% | +$54.9K |
|
2381
BioCryst Pharmaceuticals
BCRX
$2.4B
| $40K | ﹤0.01% |
11,615
+10,915
| +1,559% | +$46.8K |
|
2382
Titan International
TWI
$475M
| $37K | ﹤0.01% |
+12,707
| New | +$28K |
|
|
TRVN
2383
DELISTED
Trevena, Inc.
TRVN
| $37K | ﹤0.01% |
20
-24
| -55% | -$31.6K |
|
|
UBX
2384
DELISTED
Unity Biotechnology
UBX
| $36K | ﹤0.01% |
+1,029
| New | +$65.2K |
|
2385
Keros Therapeutics
KROS
$221M
| $35K | ﹤0.01% |
907
+9
| +1% | +$357 |
|
2386
Relmada Therapeutics
RLMD
$527M
| $35K | ﹤0.01% |
+938
| New | +$36.3K |
|
|
SURF
2387
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $35K | ﹤0.01% |
+5,056
| New | +$30.7K |
|
|
HARP
2388
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $35K | ﹤0.01% |
+207
| New | +$29.9K |
|
2389
Precision BioSciences
DTIL
$207M
| $34K | ﹤0.01% |
183
-1,665
| -90% | -$331K |
|
|
NPKI
2390
NPK International
NPKI
$1.14B
| $34K | ﹤0.01% |
32,537
+19,531
| +150% | +$35.9K |
|
2391
Flotek Industries
FTK
$1.28B
| $33K | ﹤0.01% |
+2,027
| New | +$23.6K |
|
2392
Geron
GERN
$949M
| $33K | ﹤0.01% |
19,035
-18,366
| -49% | -$34K |
|
2393
Children's Place
PLCE
$59.8M
| $33K | ﹤0.01% |
1,165
-5,200
| -82% | -$143K |
|
|
TIF
2394
DELISTED
Tiffany & Co.
TIF
| $33K | ﹤0.01% |
281
-2,380
| -89% | -$289K |
|
2395
Barnes & Noble Education
BNED
$443M
| $32K | ﹤0.01% |
+123
| New | +$27.7K |
|
|
ADAM
2396
Adamas Trust
ADAM
$883M
| $32K | ﹤0.01% |
3,109
-691
| -18% | -$7.2K |
|
2397
Energy Fuels
UUUU
$3.53B
| $32K | ﹤0.01% |
19,200
+419
| +2% | +$720 |
|
2398
New Oriental
EDU
$8.98B
| $31K | ﹤0.01% |
206
-4,494
| -96% | -$649K |
|
|
VNE
2399
DELISTED
Veoneer, Inc.
VNE
| $31K | ﹤0.01% |
2,115
-12,097
| -85% | -$146K |
|
2400
Transmedics
TMDX
$2.91B
| $30K | ﹤0.01% |
+2,173
| New | +$37.2K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q3 2020 Portfolio in Review
As of Q3 2020, Cubist Systematic Strategies held 2,736 positions worth $6.75B, up 17% from $5.79B the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.
Cubist Systematic Strategies deployed $702M of net new capital in Q3 2020, opening 363 new positions and adding to 1,147 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 93,678 shares worth $31.4M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Capital One, an estimated $35.3M trimmed.
- Cubist Systematic Strategies's largest Q3 2020 buy was State Street SPDR S&P 500 ETF Trust: 93,678 shares worth $31.4M.
- Cubist Systematic Strategies added most to Visa in Q3 2020, an estimated $38.5M increase.
- Cubist Systematic Strategies's biggest Q3 2020 reduction was Capital One, cutting an estimated $35.3M.
- Cubist Systematic Strategies fully exited Steris in Q3 2020, selling an estimated $19.6M.
- Cubist Systematic Strategies's ten largest holdings make up 4.5% of its $6.75B portfolio in Q3 2020.
- Cubist Systematic Strategies opened 363 new positions and closed 272 in Q3 2020.
- Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $6.75B.
Based on Cubist Systematic Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.